Cell Reports Medicine, 2022
Four groups of type 2 diabetes contribute to the etiological and clinical heterogeneity in newly diagnosed individuals: An IMI DIRECT study

Wesolowska-Andersen A., Brorsson C., Bizzotto R. et al.

British Journal of Dermatology, 2022
Janus kinase 1 inhibitor INCB054707 for patients with moderate‐to‐severe hidradenitis suppurativa: results from two phase II studies*

Alavi A., Hamzavi I., Brown K. et al.

International Journal of Epidemiology, 2021
Circulating proteins and risk of pancreatic cancer: a case-subcohort study among Chinese adults

Kartsonaki C., Pang Y., Millwood I. et al.

Journal of Cardiac Failure, 2021
Insulin Growth Factor Phenotypes in Heart Failure With Preserved Ejection Fraction, an INSPIRE Registry and CATHGEN Study

Haddad F., Ataam J., Amsallem M. et al.

Hemodialysis International, 2021
Multiplex proteomics as risk predictor of infection in patients treated with hemodialysis—A prospective multicenter study

Glerup R., Svensson M., Jakobsen L. et al.

Pediatric Rheumatology, 2021
Immunoprofiling of active and inactive systemic juvenile idiopathic arthritis reveals distinct biomarkers: a single-center study

Qu H., Sundberg E., Aulin C. et al.

Frontiers in Neurology, 2021
Putative Concussion Biomarkers Identified in Adolescent Male Athletes Using Targeted Plasma Proteomics

Miller M., Robinson M., Fischer L. et al.

Mucosal Immunology, 2021
Disruption of monocyte-macrophage differentiation and trafficking by a heme analog during active inflammation

Schaefer R., Callahan R., Atif S. et al.

Cancers, 2021
Identification of Potential Prognostic and Predictive Immunological Biomarkers in Patients with Stage I and Stage III Non-Small Cell Lung Cancer (NSCLC): A Prospective Exploratory Study

Vaes R., Reynders K., Sprooten J. et al.

Nature Medicine, 2021
Neurocognitive and hypokinetic movement disorder with features of parkinsonism after BCMA-targeting CAR-T cell therapy

Van Oekelen O., Aleman A., Upadhyaya B. et al.

Mediators of Inflammation, 2021
Butyrate Inhibits Osteoclast Activity In Vitro and Regulates Systemic Inflammation and Bone Healing in a Murine Osteotomy Model Compared to Antibiotic-Treated Mice

Wallimann A., Magrath W., Pugliese B. et al.

Nature Communications, 2021
Proteomic profiling of MIS-C patients indicates heterogeneity relating to interferon gamma dysregulation and vascular endothelial dysfunction

Diorio C., Shraim R., Vella L. et al.

American Journal of Respiratory and Critical Care Medicine, 2021
Alveolar, Endothelial, and Organ Injury Marker Dynamics in Severe COVID-19

Leisman D., Mehta A., Thompson B. et al.

Science Advances, 2021
Causal effects of inflammatory protein biomarkers on inflammatory diseases

Ek W., Karlsson T., Höglund J. et al.

Acta Odontologica Scandinavica, 2021
Systematic assessment of salivary inflammatory markers and dental caries in children: an exploratory study

Børsting T., Venkatraman V., Fagerhaug T. et al.

American Journal of Nephrology, 2021
Blood and Urine Biomarkers Predicting Worsening Kidney Function in Patients with Type 2 Diabetes Post-Acute Coronary Syndrome: An Analysis from the EXAMINE Trial

Ferreira J., Rossignol P., Bakris G. et al.

Fluids and Barriers of the CNS, 2021
Elevated CSF inflammatory markers in patients with idiopathic normal pressure hydrocephalus do not promote NKCC1 hyperactivity in rat choroid plexus

Lolansen S., Rostgaard N., Andreassen S. et al.

Nature Genetics, 2021
Large-scale integration of the plasma proteome with genetics and disease

Ferkingstad E., Sulem P., Atlason B. et al.

Nature Communications, 2021
Mapping the serum proteome to neurological diseases using whole genome sequencing

Png G., Barysenka A., Repetto L. et al.

Cancers, 2021
An Exploratory Analysis of Changes in Circulating Plasma Protein Profiles Following Image-Guided Ablation of Renal Tumours Provides Evidence for Effects on Multiple Biological Processes

Wah T., Zhong J., Wilson M. et al.